Review



c terminus  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Proteintech c terminus
    C Terminus, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 232 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c terminus/product/Proteintech
    Average 95 stars, based on 232 article reviews
    c terminus - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    mouse anti mmp 1  (Developmental Studies Hybridoma Bank)
    94
    Developmental Studies Hybridoma Bank mouse anti mmp 1
    Mouse Anti Mmp 1, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti mmp 1/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse anti mmp 1 - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    enac γ subunit s c terminus  (StressMarq)
    94
    StressMarq enac γ subunit s c terminus
    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of <t>ENaC's</t> γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)
    Enac γ Subunit S C Terminus, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac γ subunit s c terminus/product/StressMarq
    Average 94 stars, based on 1 article reviews
    enac γ subunit s c terminus - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    c terminus  (Sino Biological)
    94
    Sino Biological c terminus
    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of <t>ENaC's</t> γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)
    C Terminus, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c terminus/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    c terminus - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    c terminus  (Alomone Labs)
    96
    Alomone Labs c terminus
    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of <t>ENaC's</t> γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)
    C Terminus, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c terminus/product/Alomone Labs
    Average 96 stars, based on 1 article reviews
    c terminus - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    c terminus  (Proteintech)
    95
    Proteintech c terminus
    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of <t>ENaC's</t> γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)
    C Terminus, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c terminus/product/Proteintech
    Average 95 stars, based on 1 article reviews
    c terminus - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of ENaC's γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)

    Journal: Physiological Reports

    Article Title: Resistance to doxorubicin‐induced proteinuria and proteolytic activation of ENaC in 129S2 / SvPas mice

    doi: 10.14814/phy2.70667

    Figure Lengend Snippet: Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of ENaC's γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)

    Article Snippet: Lysates were then subjected to SDS‐PAGE and immunoblot using an antibody directed against the ENaC γ subunit's C‐terminus (StressMarq, #SPC‐405) as previously described (Ray et al., ).

    Techniques: Injection, Western Blot, Staining, Quantitative Proteomics, Control